Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-16
2007-01-16
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S268100, C546S268700, C546S337000, C544S296000, C544S333000, C514S256000, C514S269000, C514S340000, C514S342000, C514S357000
Reexamination Certificate
active
10523911
ABSTRACT:
N-Biarylmethylaminocycloalkanecarboxamide derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
REFERENCES:
patent: 5023265 (1991-06-01), Scherlock et al.
patent: 6919343 (2005-07-01), Wood et al.
patent: 2005/0085667 (2005-04-01), Wood et al.
patent: 2050769 (1992-03-01), None
Bock Mark G.
Kuduk Scott D.
Wood Michael R.
Aulakh Charanjit S.
Merck & Co. , Inc.
Rose David L.
Yang Mollie M.
LandOfFree
N-biarylmethyl aminocycloalkanecarboxamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-biarylmethyl aminocycloalkanecarboxamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-biarylmethyl aminocycloalkanecarboxamide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3755455